Ohio Public Employees Retirement System (OPERS)’s iTeos Therapeutics ITOS Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-58,022	Closed	-$346K	–	2341
2025 Q1	$346K	Sell	58,022 -26,198	-31%	-$192K	﹤0.01%	1556
2024 Q4	$647K	Buy	84,220 +55,394	+192%	+$476K	﹤0.01%	1452
2024 Q3	$294K	Sell	28,826 -7,952	-22%	-$121K	﹤0.01%	1493
2024 Q2	$546K	Sell	36,778 -2,225	-6%	-$31.9K	﹤0.01%	1247
2024 Q1	$532K	Buy	39,003 +1,817	+5%	+$19.8K	﹤0.01%	1249
2023 Q4	$407K	Buy	37,186 +13,207	+55%	+$131K	﹤0.01%	1289
2023 Q3	$263K	Hold	23,979	–	–	﹤0.01%	1327
2023 Q2	$317K	Hold	23,979	–	–	﹤0.01%	1336
2023 Q1	$326K	Hold	23,979	–	–	﹤0.01%	1333
2022 Q4	$468K	Sell	23,979 -3,070	-11%	-$60K	﹤0.01%	1294
2022 Q3	$515K	Buy	+27,049	New	+$623K	﹤0.01%	1324

Other funds holding ITOS

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s ITOS Position: Q2 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of iTeos Therapeutics (ITOS) in Q2 2025, closing a stake of 58,022 shares — an estimated $346K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in ITOS in Q3 2022 and held it in 11 quarters. The position peaked at $647K in Q4 2024. 137 funds tracked by Wall St. Rank hold ITOS as of Q2 2025.

Ohio Public Employees Retirement System (OPERS) reported no remaining iTeos Therapeutics position as of Q2 2025 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 58,022 iTeos Therapeutics shares in Q2 2025, an estimated $346K.
Ohio Public Employees Retirement System (OPERS) first reported a position in iTeos Therapeutics in Q3 2022 and held it in 11 quarters.
Ohio Public Employees Retirement System (OPERS)'s iTeos Therapeutics position peaked at $647K in Q4 2024.
137 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2025, filed 15 Jul 2025.